Literature DB >> 23345510

Enhanced autointegration in hyperstable simian immunodeficiency virus capsid mutants blocked after reverse transcription.

Christopher Tipper1, Joseph Sodroski.   

Abstract

After entering a host cell, retroviruses such as simian immunodeficiency virus (SIV) uncoat, disassembling the viral capsid. Rates of uncoating that are too high and too low can be detrimental to the efficiency of infection. Rapid uncoating typically leads to blocks in reverse transcription, but the basis for replication defects associated with slow uncoating is less clear. Here we characterize the phenotypes of two SIVmac239 mutants with changes, A87E and A87D, in the helix 4/5 loop of the capsid protein. These mutant viruses exhibited normal capsid morphology but were significantly attenuated for infectivity. The infectivity of wild-type and mutant SIVmac239 was not decreased by aphidicolin-induced growth arrest of the target cells. In the cytosol of infected cells, the A87E and A87D capsids remained in particulate form longer than the wild-type SIVmac239 capsid, suggesting that the mutants uncoat more slowly than the wild-type capsid. Both mutants exhibited much higher levels of autointegrated DNA forms than wild-type SIVmac239. Thus, some changes in the helix 4/5 loop of the SIVmac239 capsid protein result in capsid hyperstability and an increase in autointegration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345510      PMCID: PMC3624228          DOI: 10.1128/JVI.03239-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Differential sensitivities of retroviruses to integrase strand transfer inhibitors.

Authors:  Yasuhiro Koh; Kenneth A Matreyek; Alan Engelman
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.

Authors:  Sandhya Kortagere; Navid Madani; Marie K Mankowski; Arne Schön; Isaac Zentner; Gokul Swaminathan; Amy Princiotto; Kevin Anthony; Apara Oza; Luz-Jeannette Sierra; Shendra R Passic; Xiaozhao Wang; David M Jones; Eric Stavale; Fred C Krebs; Julio Martín-García; Ernesto Freire; Roger G Ptak; Joseph Sodroski; Simon Cocklin; Amos B Smith
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

3.  Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription.

Authors:  Amy E Hulme; Omar Perez; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-31       Impact factor: 11.205

4.  Flexible use of nuclear import pathways by HIV-1.

Authors:  KyeongEun Lee; Zandrea Ambrose; Thomas D Martin; Ilker Oztop; Alok Mulky; John G Julias; Nick Vandegraaff; Joerg G Baumann; Rui Wang; Wendy Yuen; Taichiro Takemura; Kenneth Shelton; Ichiro Taniuchi; Yuan Li; Joseph Sodroski; Dan R Littman; John M Coffin; Stephen H Hughes; Derya Unutmaz; Alan Engelman; Vineet N KewalRamani
Journal:  Cell Host Microbe       Date:  2010-03-18       Impact factor: 21.023

5.  Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.

Authors:  Jiong Shi; Jing Zhou; Vaibhav B Shah; Christopher Aiken; Kevin Whitby
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

6.  The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid.

Authors:  Kenneth A Matreyek; Alan Engelman
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  Identification and characterization of persistent intracellular human immunodeficiency virus type 1 integrase strand transfer inhibitor activity.

Authors:  Yasuhiro Koh; Hillel Haim; Alan Engelman
Journal:  Antimicrob Agents Chemother       Date:  2010-11-08       Impact factor: 5.191

8.  HIV capsid is a tractable target for small molecule therapeutic intervention.

Authors:  Wade S Blair; Chris Pickford; Stephen L Irving; David G Brown; Marie Anderson; Richard Bazin; Joan Cao; Giuseppe Ciaramella; Jason Isaacson; Lynn Jackson; Rachael Hunt; Anne Kjerrstrom; James A Nieman; Amy K Patick; Manos Perros; Andrew D Scott; Kevin Whitby; Hua Wu; Scott L Butler
Journal:  PLoS Pathog       Date:  2010-12-09       Impact factor: 6.823

9.  No interaction of barrier-to-autointegration factor (BAF) with HIV-1 MA, cone-rod homeobox (Crx) or MAN1-C in absence of DNA.

Authors:  Ying Huang; Mengli Cai; G Marius Clore; Robert Craigie
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

10.  HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency.

Authors:  Torsten Schaller; Karen E Ocwieja; Jane Rasaiyaah; Amanda J Price; Troy L Brady; Shoshannah L Roth; Stéphane Hué; Adam J Fletcher; KyeongEun Lee; Vineet N KewalRamani; Mahdad Noursadeghi; Richard G Jenner; Leo C James; Frederic D Bushman; Greg J Towers
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

View more
  4 in total

1.  Contribution of glutamine residues in the helix 4-5 loop to capsid-capsid interactions in simian immunodeficiency virus of macaques.

Authors:  Christopher Tipper; Joseph G Sodroski
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

2.  HIV-1 capsid is involved in post-nuclear entry steps.

Authors:  Nan-Yu Chen; Lihong Zhou; Paul J Gane; Silvana Opp; Neil J Ball; Giuseppe Nicastro; Madeleine Zufferey; Cindy Buffone; Jeremy Luban; David Selwood; Felipe Diaz-Griffero; Ian Taylor; Ariberto Fassati
Journal:  Retrovirology       Date:  2016-04-23       Impact factor: 4.602

Review 3.  Retroviral DNA Integration.

Authors:  Paul Lesbats; Alan N Engelman; Peter Cherepanov
Journal:  Chem Rev       Date:  2016-05-20       Impact factor: 60.622

Review 4.  A model for cofactor use during HIV-1 reverse transcription and nuclear entry.

Authors:  Laura Hilditch; Greg J Towers
Journal:  Curr Opin Virol       Date:  2014-01-14       Impact factor: 7.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.